The DOI matches its Crossref record; 6 of the 10 references it cites were found in a registry or an index.
Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014
Open accessAbstract
The United States is experiencing an epidemic of drug overdose (poisoning) deaths. Since 2000, the rate of deaths from drug overdoses has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). CDC analyzed recent multiple cause-of-death mortality data to examine current trends and characteristics of drug overdose deaths, including the types of opioids associated with drug overdose deaths. During 2014, a total of 47,055 drug overdose deaths occurred in the United States, representing a 1-year increase of 6.5%, from 13.8 per 100,000 persons in 2013 to 14.7 per 100,000 persons in 2014. The rate of drug overdose deaths increased significantly for both sexes, persons aged 25-44 years and ≥55 years, non-Hispanic whites and non-Hispanic blacks, and in the Northeastern, Midwestern, and Southern regions of the United States. Rates of opioid overdose deaths also increased significantly, from 7.9 per 100,000 in 2013 to 9.0 per 100,000 in 2014, a 14% increase. Historically, CDC has programmatically characterized all opioid pain reliever deaths (natural and semisynthetic opioids, methadone, and other synthetic opioids) as "prescription" opioid overdoses (1). Between 2013 and 2014, the age-adjusted rate of death involving methadone remained unchanged; however, the age-adjusted rate of death involving natural and semisynthetic opioid pain relievers, heroin, and synthetic opioids, other than methadone (e.g., fentanyl) increased 9%, 26%, and 80%, respectively. The sharp increase in deaths involving synthetic opioids, other than methadone, in 2014 coincided with law enforcement reports of increased availability of illicitly manufactured fentanyl, a synthetic opioid; however, illicitly manufactured fentanyl cannot be distinguished from prescription fentanyl in death certificate data. These findings indicate that the opioid overdose epidemic is worsening. There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Opioids accounted for 61% of all drug-related overdoses in 2014 (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
In the citing paper
“Between 2000 and 2014, nearly a half million people in the US died from a drug overdose (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
Citations
Cites
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350
The Changing Face of Heroin Use in the United States
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.366 · Cited by 1,169
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,014
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.
Jones, C. M., Logan, J. E., Gladden, R. M., & Bohm, M. K. (2015) · PubMed Central · Cited by 476
Injury in the United States; 2007 chartbook
Bergen, G., Chen, L., & Warner, M. (2008) · Cited by 120
Davis, G. G. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0323-x · Cited by 99
Cited by
Sorted by citations
Items 101–200 of 1,001
Henningfield, J. E., Fant, R. V., & Wang, D. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4813-4 · Cited by 151
Krawczyk, N., Feder, K. A., Saloner, B. K., Crum, R. M., Kealhofer, M., & Mojtabai, R. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.02.006 · Cited by 137
Addressing the Opioid Epidemic: Is There a Role for Physician Education?
Schnell, M. K., & Currie, J. (2017) · American Journal of Health Economics · doi:10.1162/ajhe_a_00113 · Cited by 142
Arrest etiology among patients resuscitated from cardiac arrest
Chen, N., Callaway, C. W., Guyette, F. X., Rittenberger, J. C., Doshi, A. A., Dezfulian, C., & Elmer, J. (2018) · Resuscitation · doi:10.1016/j.resuscitation.2018.06.024 · Cited by 140
“Over time, the incidence of shockable rhythms has fallen with improved secondary prevention,[7] the population of the United States has aged and become more chronically ill,[18] and new medical conditions like opioid dependence and overdose are becoming more prevalent.[19] Important secular trends in the epidemiology…”
Green, T. C., Case, P., Fiske, H., Baird, J. B., Cabral, S., Burstein, D., Schwartz, V., Potter, N., Walley, A. Y., & Bratberg, J. P. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.01.013 · Cited by 147
Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care
Liebschutz, J. M., Xuan, Z., Shanahan, C. W., Larochelle, M. R., Keosaian, J. E., Beers, D., Guara, G., O’Connor, K., Alford, D. P., Parker, V. A., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2468 · Cited by 142
High willingness to use rapid fentanyl test strips among young adults who use drugs
Krieger, M. S., Yedinak, J. L., Buxton, J. A., Lysyshyn, M., Bernstein, E., Rich, J. D., Green, T. C., Hadland, S. E., & Marshall, B. D. L. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0213-2 · Cited by 142
Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving Treatment
Saia, K., Schiff, D. M., Wachman, E. M., Mehta, P., Vilkins, A. L., Sia, M., Price, J., Samura, T., DeAngelis, J., Jackson, C. V., et al. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0168-9 · Cited by 136
Multiple DSM‐5 substance use disorders: A national study of US adults
McCabe, S. E., West, B. T., Jutkiewicz, E. M., & Boyd, C. J. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2625 · Cited by 133
State legal innovations to encourage naloxone dispensing
Davis, C. S., & Carr, D. H. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.11.007 · Cited by 135
Dunn, L. K., Yerra, S., Fang, S., Hanak, M. F., Leibowitz, M. K., Tsang, S., Durieux, M. E., Nemergut, E. C., & Naik, B. I. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003338 · Cited by 135
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages
Haffajee, R. L., Mello, M. M., Zhang, F., Zaslavsky, A. M., Larochelle, M. R., & Wharam, J. F. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1321 · Cited by 135
Perioperative Opioids and Public Health
Kharasch, E. D., & Brunt, L. M. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001012 · Cited by 132
Cost‐effectiveness of emergency department‐initiated treatment for opioid dependence
Busch, S. H., Fiellin, D. A., Chawarski, M. C., Owens, P. H., Pantalon, M. V., Hawk, K. F., Bernstein, S. L., O’Connor, P. G., & D’Onofrio, G. (2017) · Addiction · doi:10.1111/add.13900 · Cited by 128
Kandel, D. B., Hu, M., Griesler, P. C., & Wall, M. M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.047 · Cited by 131
Wong, A., Plasek, J. M., Montecalvo, S. P., & Zhou, L. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2151 · Cited by 135
Irvine, M. A., Oller, D., Boggis, J., Bishop, B., Coombs, D., Wheeler, E., Doe-Simkins, M., Walley, A. Y., Marshall, B. D. L., Bratberg, J., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00304-2 · Cited by 127
“3–6 The evolving nature of the crisis requires approaches that reduce mortality and morbidity across all three epidemic types.”
BackgroundSubstance use in rural Central Appalachia: Current status and treatment considerations.
Moody, L. N., Satterwhite, E., & Bickel, W. K. (2017) · Journal of Rural Mental Health · doi:10.1037/rmh0000064 · Cited by 155
Rosenberg, J. M., Bilka, B. M., Wilson, S. M., & Spevak, C. (2017) · Pain Medicine · doi:10.1093/pm/pnx203 · Cited by 128
Polimanti, R. A., Walters, R. K., Johnson, E. C., McClintick, J. N., Adkins, A. E., Adkins, D. E., Bacanu, S., Bierut, L. J., Bigdeli, T. B., Brown, S. A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0677-9 · Cited by 125
Gray, M. E., McQuade, E. T. R., Scheld, W. M., & Dillingham, R. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3408-y · Cited by 124
Emerging Trend in the Pharmacotherapy of Osteoarthritis
Zhang, W., Robertson, B. A., Zhao, J., Chen, W., & Xu, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00431 · Cited by 124
“S, a 14% increase from 2013 to 2014 (27).”
The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse
Soffin, E. M., Lee, B. H., Kumar, K. K., & Wu, C. L. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.11.019 · Cited by 127
Singh, G. K., Kim, I. E., Girmay, M., Perry, C., Daus, G. P., Vedamuthu, I. P., Reyes, A. D. L., Ramey, C., Martin, E. K., & Allender, M. (2019) · International Journal of Maternal and Child Health and AIDS · doi:10.21106/ijma.284 · Cited by 125
Wen, H., Schackman, B. R., Aden, B., & Bao, Y. (2017) · Health Affairs · doi:10.1377/hlthaff.2016.1141 · Cited by 122
Opioid misuse in gastroenterology and non-opioid management of abdominal pain
Szigethy, E., Knisely, M., & Drossman, D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.141 · Cited by 117
Green, C. A., Perrin, N., Janoff, S. L., Campbell, C. I., Chilcoat, H. D., & COPLAN, P. M. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4157 · Cited by 120
Effects of Drugs of Abuse on the Blood-Brain Barrier: A Brief Overview
Pimentel, E., Sivalingam, K., Doke, M., & Samikkannu, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00513 · Cited by 120
Hasak, J. M., Bettlach, C. L. R., Santosa, K. B., Larson, E. L., Stroud, J., & Mackinnon, S. E. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2017.11.023 · Cited by 118
Chang, H., Kharrazi, H. H. K., Bodycombe, D., Weiner, J. P., & Alexander, G. C. (2018) · BMC Medicine · doi:10.1186/s12916-018-1058-y · Cited by 120
Duber, H. C., Barata, I. A., Cioè‐Peña, E., Liang, S. Y., Ketcham, E. M., Macias‐Konstantopoulos, W., Ryan, S. A., Stavros, M., & Whiteside, L. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.04.007 · Cited by 116
“Since 2000, there has been a 200% increase in the rate of opioid overdose deaths, with heroin and synthetic opioids other than methadone considered the primary drivers.(8) Within the US health care system, emergency departments (EDs) are often at the forefront of the opioid”
BackgroundPharmacists' readiness to provide naloxone in community pharmacies in West Virginia
Thornton, J. D., Lyvers, E., Scott, V., & Dwibedi, N. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.12.070 · Cited by 117
“20,21 EPPM has 4 key constructs that need to be measured to categorize individuals into 4 groups with unique educational goals: (1) perceived severity, (2) perceived susceptibility, (3) response efficacy, and (4) self-efficacy.”
BackgroundHsu, D. J., McCarthy, E., Stevens, J., & Mukamal, K. (2017) · Addiction · doi:10.1111/add.13795 · Cited by 106
Use of prescription opioids before and after an operation for chronic pain (lumbar fusion surgery)
Deyo, R. A., Hallvik, S. E., Hildebran, C., Marino, M., O’Kane, N., Carson, J., Otterloo, J. V., Wright, D. A., Millet, L. M., & Wakeland, W. W. (2018) · Pain · doi:10.1097/j.pain.0000000000001202 · Cited by 119
Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature
Lyons, R. M., Yule, A. M., Schiff, D. M., Bagley, S. M., & Wilens, T. E. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0013 · Cited by 116
“Indeed, the use of opioids such as heroin (Hakansson et al. 2008) and/or fentanyl has been identified as risk factors of drug OD in adults (Rudd et al. 2016; Somerville et al. 2017).”
BackgroundRisk markers for fatal and non-fatal prescription drug overdose: a meta-analysis
Brady, J. E., Giglio, R. E., Keyes, K. M., DiMaggio, C. J., & Li, G. (2017) · Injury Epidemiology · doi:10.1186/s40621-017-0118-7 · Cited by 116
Frost, M., Bailey, G. L., Lintzeris, N., Strang, J., Dunlop, A. J., Nunes, E. V., Jansen, J. B., Frey, L. C., Weber, B., Haber, P., et al. (2019) · Addiction · doi:10.1111/add.14636 · Cited by 114
Burr, N. E., Smith, C., West, R. M., Hull, M. A., & Subramanian, V. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.10.022 · Cited by 114
Strıke, C., & Watson, T. M. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.02.005 · Cited by 113
Broz, D., Carnes, N., Chapin-Bardales, J., Jarlais, D. C. D., Handanagić, S., Jones, C. M., McClung, R. P., & Asher, A. K. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.05.044 · Cited by 112
Krieter, P. A., Chiang, N., Gyaw, S., Skolnick, P., Crystal, R., Keegan, F., Aker, J., Beck, M., & Harris, J. J. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.759 · Cited by 111
Current status of opioid addiction treatment and related preclinical research
Kreek, M. J., Reed, B., & Butelman, E. R. (2019) · Science Advances · doi:10.1126/sciadv.aax9140 · Cited by 111
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
Powell, D., Alpert, A. E., & Pacula, R. L. (2019) · Health Affairs · doi:10.1377/hlthaff.2018.05232 · Cited by 110
National trends in long‐term use of prescription opioids
Mojtabai, R. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4278 · Cited by 109
Criminal justice continuum for opioid users at risk of overdose
Brinkley‐Rubinstein, L., Zaller, N. D., Martino, S., Cloud, D. H., McCauley, E., Heise, A., & Seal, D. W. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.02.024 · Cited by 117
Mash, D. C., Duque, L., Page, B., & Allen-Ferdinand, K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00529 · Cited by 109
“Opioid use disorder is a deadly disease that costs the US healthcare system hundreds of billions of dollars each year (Rudd et al., 2016).”
Ronquest, N. A., Willson, T. M., Montejano, L. B., Nadipelli, V. R., & Wollschlaeger, B. (2018) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s150253 · Cited by 107
Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing
Faul, M., Lurie, P. G., Kinsman, J. M., Dailey, M. W., Crabaugh, C., & Sasser, S. M. (2017) · Prehospital Emergency Care · doi:10.1080/10903127.2017.1315203 · Cited by 112
Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts
Rose, M. E. (2017) · Pain Medicine · doi:10.1093/pm/pnx048 · Cited by 110
Surveillance for Violent Deaths — National Violent Death Reporting System, 27 States, 2015
Jack, S. P. D., Petrosky, E. Y., Lyons, B. H., Blair, J. M., Ertl, A. M., Sheats, K. J., & Betz, C. J. (2018) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6711a1 · Cited by 106
“Whether these deaths were the result of unintentional drug poisonings (which have increased substantially in recent years) (29) or suicides is unknown.”
BackgroundGoodman, D., Saunders, E. C., & Wolff, K. B. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-02872-5 · Cited by 121
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
Kripke, D. F. (2016) · F1000Research · doi:10.12688/f1000research.8729.1 · Cited by 106
“Short and long sleep and sleeping pills: Is increased mortality associated? Arch Gen Psychiatry 1979;36(1):103-16.”
Barriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States
Patrick, S. W., Buntin, M. B., Martin, P., Scott, T. A., Dupont, W. D., Richards, M. R., & Cooper, W. O. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1488336 · Cited by 108
“to opioid pain relievers (OPRs) have recently plateaued, deaths associated with heroin and fentanyl use have grown exponentially.(26) Appalachia has been disproportionately impacted by opioid deaths.”
BackgroundKarhade, A. V., Ogink, P. T., Thio, Q. C. B. S., Cha, T. D., Gormley, W. B., Hershman, S. H., Smith, T. R., Mao, J., Schoenfeld, A. J., Bono, C. M., et al. (2019) · The Spine Journal · doi:10.1016/j.spinee.2019.06.002 · Cited by 105
Macmadu, A., Carroll, J. J., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.01.014 · Cited by 104
Association of Opioid Usage with Spinal Cord Stimulation Outcomes
Sharan, A. D., Riley, J. P., Falowski, S. M., Pope, J. E., Connolly, A. T., Karst, E., Dalal, N., & Provenzano, D. A. (2017) · Pain Medicine · doi:10.1093/pm/pnx262 · Cited by 103
A case of U-47700 overdose with laboratory confirmation and metabolite identification
Jones, M., Hernandez, B. S., Janis, G. C., & Stellpflug, S. J. (2016) · Clinical Toxicology · doi:10.1080/15563650.2016.1209767 · Cited by 103
Suicide Deaths With Opioid Poisoning in the United States: 1999–2014
Braden, J. B., Edlund, M. J., & Sullivan, M. D. (2017) · American Journal of Public Health · doi:10.2105/ajph.2016.303591 · Cited by 102
Social networking online to recover from opioid use disorder: A study of community interactions
D’Agostino, A. R., Optican, A., Sowles, S. J., Krauss, M. J., Lee, K. E., & Cavazos‐Rehg, P. A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.010 · Cited by 102
Opioid Use by Patients After Rhinoplasty
Patel, S. S., Sturm, A. K., Bobian, M. R., Svider, P. F., Zuliani, G. F., & Kridel, R. (2017) · JAMA Facial Plastic Surgery · doi:10.1001/jamafacial.2017.1034 · Cited by 101
McKnight, C. A., & Jarlais, D. C. D. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.08.004 · Cited by 104
Cook, D. J., Kaskovich, S., Pirkle, S., Mica, M. C., Shi, L. L., & Lee, M. J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.12.023 · Cited by 101
Two cases of intoxication with new synthetic opioid, U-47700
Domanski, K., Kleinschmidt, K., Schulte, J., Fleming, S. W., Frazee, C. C., Menendez, A., & Tavakoli, K. (2016) · Clinical Toxicology · doi:10.1080/15563650.2016.1209763 · Cited by 100
Sullivan, M. A., Bisaga, A. M., Pavlicová, M., Choi, C. J., Mishlen, K., Carpenter, K. M., LEVIN, F. R., Dakwar, E., Mariani, J. J., & Nunes, E. V. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050548 · Cited by 100
Documenting and Explaining the 2015 Homicide Rise: Research Directions
Rosenfeld, R. (2016) · National Institute of Justice (U.S.) · Cited by 99
Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department
Rowe, C. L., Vittinghoff, E., Santos, G., Behar, E., Turner, C., & Coffin, P. O. (2016) · Academic Emergency Medicine · doi:10.1111/acem.13121 · Cited by 99
Turning the Tide or Riptide? The Changing Opioid Epidemic
Kertesz, S. G. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1261070 · Cited by 99
Forster, M., Gower, A. L., Borowsky, I. W., & McMorris, B. J. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.01.004 · Cited by 98
Secular trends in opioid prescribing in the USA
Pezalla, E. J., Rosen, D., Erensen, J. G., Haddox, J. D., & Mayne, T. J. (2017) · Journal of Pain Research · doi:10.2147/jpr.s129553 · Cited by 98
Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids
Lagisetty, P., Healy, N. A., Garpestad, C., Jannausch, M. L., Tipirneni, R., & Bohnert, A. S. B. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.6928 · Cited by 100
Cernasev, A., Hohmeier, K. C., Frederick, K. D., Jasmin, H., & Gatwood, J. D. (2021) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2021.100029 · Cited by 98
Oral Multimodal Analgesia for Total Joint Arthroplasty
Golladay, G. J., Balch, K., Dalury, D. F., Satpathy, J., & Jiranek, W. A. (2017) · The Journal of Arthroplasty · doi:10.1016/j.arth.2017.05.002 · Cited by 97
Kral, A. H., & Davidson, P. J. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.010 · Cited by 103
Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
Mars, S. G., Ondocsin, J., & Ciccarone, D. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0232-z · Cited by 96
Opioid free anesthesia: feasible?
Chia, P. A., Cannesson, M. P., & Bui, C. C. M. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000878 · Cited by 96
Interventions for Postsurgical Opioid Prescribing
Wetzel, M. W., Hockenberry, J. M., & Raval, M. V. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.2730 · Cited by 94
Neuroimmune mechanisms of psychostimulant and opioid use disorders
Hofford, R. S., Russo, S. J., & Kiraly, D. D. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14143 · Cited by 95
Current Concepts in Methadone Metabolism and Transport
Kharasch, E. D. (2017) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.326 · Cited by 95
Deaths of Despair or Drug Problems?
Ruhm, C. J. (2018) · National Bureau of Economic Research · doi:10.3386/w24188 · Cited by 93
The North American opioid epidemic: current challenges and a call for treatment as prevention
Vashishtha, D., Mittal, M. L., & Werb, D. (2017) · Harm Reduction Journal · doi:10.1186/s12954-017-0135-4 · Cited by 94
Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance
Slavova, S. S., Costich, J. F., Bunn, T. L., Luu, H., Singleton, M. D., Hargrove, S. L., Triplett, J. S., Quesinberry, D. B., Ralston, W., & Ingram, V. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.051 · Cited by 97
The use of cannabis in response to the opioid crisis: A review of the literature
Vyas, M. B., LeBaron, V. T., & Gilson, A. M. (2017) · Nursing Outlook · doi:10.1016/j.outlook.2017.08.012 · Cited by 94
“…of MC legalization are unclear, there have been zero reported deaths directly related to cannabis overdose, whereas there were 33,091 deaths related to all opioids in 2015, over 15,000 of which were attributed to POMs such as hydrocodone, oxycodone, and fentanyl (CDC, 2015; Rudd et al., 2016).”
BackgroundBuchanich, J. M., Balmert, L. C., Williams, K. E., & Burke, D. S. (2018) · Public Health Reports · doi:10.1177/0033354918774330 · Cited by 93
Gaither, J. R., Gordon, K. S., Crystal, S., Edelman, E. J., Kerns, R. D., Justice, A. C., Fiellin, D. A., & Becker, W. C. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.05.033 · Cited by 97
Schalkoff, C. A., Lancaster, K. E., Gaynes, B. N., Wang, V., Pence, B. W., Miller, W. C., & Go, V. F. (2020) · Substance Abuse · doi:10.1080/08897077.2019.1635555 · Cited by 94
“Rates of drug poisoning deaths have increased during the span of 1999–2009 from approximately 4 per 100,000 persons to 12 per 100,000, and the CDC estimates that drug overdose deaths have increased 137% since 2000.(3,4) This increase in drug use and overdose arose from the prescription opioid epidemic and has been lin…”
Singh, J. A., & Cleveland, J. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229174 · Cited by 98
Sandbrink, F., Murphy, J. L., Johansson, M., Olson, J. L., Edens, E. L., Clinton-Lont, J., Sall, J., Spevak, C., VA/DoD Guideline Development Group, Sandbrink, F., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-2917 · Cited by 101
Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014.
Hirschtritt, M. E., Delucchi, K. L., & Olfson, M. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.12.010 · Cited by 93
Bardwell, G., Fleming, T., Collins, A. B., Boyd, J., & McNeil, R. (2019) · Journal of Urban Health · doi:10.1007/s11524-018-0294-y · Cited by 93
The Critical Care Crisis of Opioid Overdoses in the United States
Stevens, J. P., Wall, M. J., Novack, L., Marshall, J. P., Hsu, D. J., & Howell, M. D. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-022oc · Cited by 93
Disability status and prescription drug misuse among U.S. adults
Ford, J. A., Hinojosa, M. S., & Nicholson, H. L. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.05.019 · Cited by 93
Patients’ Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians
Henry, S. G., Paterniti, D. A., Feng, B., Iosif, A., Kravitz, R. L., Weinberg, G., Cowan, P., & Verba, S. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.09.001 · Cited by 96
Intravenous Lidocaine for Acute Pain: A Systematic Review
Masic, D., Liang, E., Long, C., Sterk, E. J., Barbas, B., & Rech, M. A. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2189 · Cited by 93
“The misuse and abuse of opioid prescription pain medication has resulted in an opioid crisis, with more than 100 Americans dying from an opioid overdose every day.(5) Due to the ongoing opioid crisis, health care providers are encouraged to explore alternative approaches to pain management.”
BackgroundPatrick, S. W., Faherty, L. J., Dick, A. W., Scott, T. A., Dudley, J. A., & Stein, B. D. (2019) · JAMA · doi:10.1001/jama.2018.20851 · Cited by 93
Mason, M., Soliman, R., Kim, H. S., & Post, L. A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.42982 · Cited by 93
Endogenous opioid systems alterations in pain and opioid use disorder
Higginbotham, J. A., Markovic, T., Massaly, N., & Morón, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1014768 · Cited by 94
“Department of Health and Human Services, 2019) which led to the initial wave of prescription overdose deaths (Rudd et al., 2016).”
The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio
Weiner, S. G., Baker, O. N., Poon, S. J., Rodgers, A. F., Garner, C., Nelson, L. S., & Schuur, J. D. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.03.057 · Cited by 91
Samuels, E. A., Baird, J. R., Yang, E. S., & Mello, M. J. (2018) · Academic Emergency Medicine · doi:10.1111/acem.13545 · Cited by 94
Carlson, R. G., Daniulaityte, R., Silverstein, S. M., Nahhas, R. W., & Martins, S. S. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102722 · Cited by 90
Peckham, A. M., Fairman, K. A., & Sclar, D. A. (2017) · Drug Safety · doi:10.1007/s40264-017-0595-1 · Cited by 91
Metadata
- Authors
- Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M.
- Affiliations
- National Center for Injury Prevention and Control (US)
- Venue
- MMWR Morbidity and Mortality Weekly Report
- Published
- 2016-01-01
- Volume
- 64
- Issue
- 50-51
- Pages
- 1378-1382
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2292748019
- Cited by
- 1,859
- References
- 10
- Citations by year
- 2026: 16 · 2025: 35 · 2024: 42 · 2023: 79 · 2022: 118 · 2021: 144 · 2020: 242 · 2019: 271 · 2018: 332 · 2017: 406 · 2016: 169
- FWCI
- 321.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- drug overdose deaths, opioid overdose deaths, opioid epidemic, heroin, illicitly manufactured fentanyl, synthetic opioids, methadone, mortality trends, age-adjusted death rates, opioid use disorder, opioid supply
- MeSH terms
- Adolescent, Adult, Aged, Analgesics, Opioid, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, United States, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review